MDCX Stock Analysis: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$0.30
-0.01 (-1.89%)
▼
5d:
+5.46%
30d:
-35.8%
90d:
+3.11%
HOLD
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 10, 2026
5d
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MDCX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MDCX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $0.30, which is considered oversold relative to its 30-day fair value range of $0.32 to $0.44.
Technical Outlook: Technically, MDCX is in a downtrend. Immediate support is located at $0.25, while resistance sits at $0.42.
Market Sentiment: MDCX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.50 (+1395.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MDCX is in a downtrend. Immediate support is located at $0.25, while resistance sits at $0.42.
Market Sentiment: MDCX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.50 (+1395.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.32 -
$0.44
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1395.0% below Wall St target ($4.50)
Trading Range Analysis
30-Day Trading Range
$0.32 -
$0.44
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.25
Resistance Level
$0.42
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.84
Wall Street Target
$4.50
(+1395.0%)
Share & Embed Analysis
Last updated: August 04, 2026 10:31 AM ET
Data refreshes hourly during market hours. Next update: 11:31 AM
Data refreshes hourly during market hours. Next update: 11:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1277 | 49 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 56 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$357 | 58 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$270 | 57 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$234 | 56 HOLD |
